INSYS Therapeutics announced that it has reached an agreement in principle with the Department of Justice to settle the DOJ’s civil and criminal investigation into inappropriate sales and commercial practices by some former company employees. This agreement in principle is subject to the negotiation of final settlement documents with the government. Consistent with previous public statements and disclosures, the terms of this agreement in principle call for INSYS to pay $150M over five years, with the potential for contingency-based payments associated with certain events that, if they were to occur, management estimates would require additional payments ranging from $0 to $75M. INSYS also expects that a final settlement would include other material non-financial terms and conditions which will also be subject to negotiation.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.